Citation Impact
Citing Papers
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
2015
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
2017
Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
2014
Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm<subtitle>A Randomized Trial</subtitle>
2009 Standout
Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
2015
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
2016
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
2016
Systemic sclerosis
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effect of Mibefradil, a T-Type Calcium Channel Blocker, on Morbidity and Mortality in Moderate to Severe Congestive Heart Failure
2000
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
New Equations to Estimate GFR in Children with CKD
2009 Standout
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
2013 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2014
Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program
2005
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
2014
Remodelling the extracellular matrix in development and disease
2014 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
2013
Current Guidelines on Stress Ulcer Prophylaxis
1997
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Revised Equations for Estimated GFR From Serum Creatinine in Japan
2009 Standout
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
2016
Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor
2014
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Decreased Kidney Function Among Agricultural Workers in El Salvador
2012
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
2011
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
2012
Ventilator-associated Pneumonia
2002 Standout
5 Amidines and Guanidines in Medicinal Chemistry
1993
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2018
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Mechanistic Studies on the Cu-Catalyzed Three-Component Reactions of Sulfonyl Azides, 1-Alkynes and Amines, Alcohols, or Water: Dichotomy via a Common Pathway
2008 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications
2013
Additions to Metal-Activated Organonitriles
2002 Standout
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
2003
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
2017
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
2020
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Linagliptin treatment in subjects with type 2 diabetes with and without mild‐to‐moderate renal impairment
2014
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Works of Atef Halabi being referenced
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
2010
Negative chronotropic effects of nizatidine.
1991
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase‐4 inhibitor linagliptin *
2011
Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method
2004
Clinical Aspects of Cardiovascular Effects of H2‐Receptor Antagonists
1995
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
2011
Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension
1992
PP192—Pharmacokinetics of Selexipag in Subjects with Severe Renal Impairment Compared with Healthy Subjects
2013
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor, in subjects with renal impairment
2013
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94–8862) in Individuals With Renal Impairment
2016